secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001104659-24-072272
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus annual meeting results: directors elected, equity plan increase approved
--------------------------------------------------------------------------------

- Class III directors Georges Gemayel and Bethany Sensenig elected with ~48.4M and ~48.6M votes for, respectively.
- Say-on-pay proposal approved with 48.2M for, 2.3M against, 1.9M broker non-votes.
- Ratification of KPMG as auditor passed with 52.2M for, 272.9K against; no broker non-votes.
- Amendment to 2021 Equity Incentive Plan to increase shares passed with 45.5M for, 5.0M against, 1.9M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000110465924072272/0001104659-24-072272-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000110465924072272/tm2417381d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-072272

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer